Channel Sponsor - Valuation

Sponsored by VMG Health | gregk@vmghealth.com | (214) 369-4888

AmSurg Shares Rise in Value After $2.35B Sheridan Deal Announcement

Share on Facebook
Raymond James analyst John Ransom set AmSurg’s price target at $60 and upgraded his recommendation to “buy,” according to a Value Walk report.

The upgrade was made closely following AmSurg’s announcement of intention to acquire Sheridan Healthcare for $2.35 billion.

More Articles on Transactions and Valuation Issues:
4 Recent ASC Industry Acquisitions
Beloit Health System ASC Project Remains in Limbo
3 Recently Opened & Expanded Ambulatory Surgery Centers

© Copyright ASC COMMUNICATIONS 2014. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

New From Becker's ASC Review

Dr. Majid Jamali to open oral, maxillofacial surgery center in New York

Read Now